6533b826fe1ef96bd1283a05
RESEARCH PRODUCT
LOWER RESPONSE TO INTRAVESICAL ADJUVANT THERAPY IN HIGH-RISK BLADDER CANCER COULD BE RELATED TO THE UROTHELIAL EXPRESSION OF EGFR
Cristina Scalici GesolfoSebastiano BilloneAlessio GuarneriMarco VellaAlessandro PerezGraziella CangemiAntonio RussoAlchiede SimonatoVincenzo Serrettasubject
EGFR bladder cancerSettore MED/24 - Urologiayear | journal | country | edition | language |
---|---|---|---|---|
2017-04-22 |